StrataCTX device to reduce steroid use in CTCL itch
Part of Cancer clinical trials.
This trial studies StrataCTX®, a device used with skin treatment, to help people with CTCL (a type of skin lymphoma) who have hard-to-control itch, steroid dependence, or skin reactions. It may help reduce the need for steroid creams or pills while improving symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have been diagnosed with CTCL
- You have skin issues like itch that won’t go away, need frequent topical steroids, or have a rash from treatment
- You have problems related to topical mechlorethamine gel (such as contact dermatitis) or treatment-related rash
- You can apply skin treatments yourself (or have help to do so)
- You are not taking oral steroid pills and you are not currently on radiation
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an experimental drug called PTX 100 for people with cutaneous T-cell lymphoma (CTCL) that has come back after at least two prior treatments. It aims to see if PTX 100 can help shrink tumors or slow the disease.
This study collects stored tissue samples (from skin or other needed procedures) from people with CTCL, Sézary syndrome, or lymphomatoid papulosis, especially when you are starting or changing treatment. It’s meant to help researchers learn more about these illnesses and may support future research.
This trial tests whether a medicated skin gel (StrataXRT) can better prevent painful skin rash (“acute dermatitis”) in people with head and neck cancer who receive chemotherapy and radiation at the same time. If you’re eligible, you may get the study skin product and help doctors find a safer, more comfortable way to protect the skin during treatment.
This trial is testing new treatment plans based on the genetic type of your cutaneous T-cell lymphoma (CTCL). It's for people whose CTCL did not respond well to standard skin treatments.
This study tests whether a new topical treatment, StrataMGT, can reduce symptoms of vulvar lichen sclerosus. It is for women with moderate to severe symptoms who are already using a stable topical prescription.
This trial tests two medications (golidocitinib and chidamide) for people with a type of lymphoma that affects the skin. The combo may help control the disease when other treatments haven't worked or have stopped working.
Hear when a new CTCL trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.